Photo of Roopa Kohli-Seth

Roopa Kohli-Seth

Print ProfilePrint Profile


  • Critical Care Medicine


  • Residency, Internal Medicine
    Grace Hospital

  • Fellowship, Critical Care
    Mount Sinai Hospital



  • \tOropello JM, Benjamin E, Manasia A, Kohli-Seth R, DelGiudice R, Hufanda J. A Phase 2 study to determine the efficacy of Sivelestat in patients with Acute Lung Injury \r\n
  • Benjamin E Kohli-Seth R, Oropello JM Manasia A, Hannon E, DelGiudice R, Hufanda J Benign postoperative hyperlactatemia in Neurosurgical Patients \r\n\r\n
  • Benjamin E, Oropello JM, Manasia A, Kohli-Seth R, DelGiudice R, Hufanda J. Beginning and Ending Supportive therapy (BEST) for the Kidney Study \r\n
  • Oropello JM, Benjamin E, Manasia A, Kohli-Seth R, DelGiudice R, Hufanda J. Phase 3 multicenter randomized placebo study of PHP in sepsis with Shock. \r\n\r\n
  • A Manasia, Benjamin E, Oropello JM, R. Kohli-Seth R DelGiudice, J Hufanda. Limited transthoracic echocardiography (TTE) by non-cardiologist surgical intensivists. \r\n \r\n
  • Oropello JM, Benjamin E, Manasia A, R. Kohli-Seth R, DelGiudice, J Hufanda. J4A-MC-EZZI. A phase 2b Study to determine the efficacy and safety of LY315920 in patients with severe sepsis.\r\n
  • Publications

    Kohli-Seth R, Oropello JM. The future of bedside monitoring. Crit Care Clin 2000 October; 16(4): 557-578.

    Benjamin E, Kohli-Seth R, Hannon E, Manasia A, Chhabra S, Oropello J. Benign postoperative hyperlactatemia in neurosurgical patients. Indonesian Journal of Shock and Critical;.

    Industry Relationships

    Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.

    Dr. Kohli-Seth did not report having any of the following types of financial relationships with industry during 2012 and/or 2013: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.

    Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website at Patients may wish to ask their physician about the activities they perform for companies.

    Edit profile in Sinai Central


    1468 Madison Avenue
    6th Floor
    New York, NY 10029

    Tel: 212-241-8867
    Fax: 212-860-3667
    Get Directions